The most common areas of treatment include the face and neck and can also be used for the dcolletage, hands, arms, knees and abdomen area where it would effectively treat skin laxity
Cellular Energy &
However, despite previous reports on the potential advantage posed by GLP1-based multi-agonists in the management of obesity and metabolic disease, as recently exemplified by the dramatic body weight-lowering actions of the GLP1/GIP dual agonist, tirzepatide 47 , to our knowledge, no study has addressed to date the pharmacological characterization of GLP1-based unimolecular multi-agonists for management of reproductive and metabolic alterations of PCOS, using suitable preclinical models, as pre-requisite for their application in clinics
The Klinic team checks in every 30 days to track your progress, adjust your dose, and offer support via our app and 24/7 chat
This distinction matters enormously right now, and patients need to understand it